世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000032033

ヒト用ワクチンの世界市場(2022-2026)

TechNavio

Global Human Vaccine Market 2022-2026

発刊日 2022/05/05

言語英語

体裁PDF/120ページ

ライセンス/価格120ページ

0000032033

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、ヒト用ワクチン市場を分析します。

世界のヒト用ワクチン市場は、予測期間中に約7.73 %のCAGRで推移し、2022年から2026年の間に203億7,000万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。ワクチン分野への投資の増加、政府による公的な予防接種プログラム、ワクチンに関する一般市民の情報へのアクセスの向上が市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ 投与経路別
      ◇ 筋肉内
      ◇ 皮下
      ◇ 経口
      ◇ その他
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

本調査は、高所得国と発展途上国におけるワクチンの多様な需要を、今後数年間のヒトワクチン市場の成長を促進する主な理由の1つとして特定しています。また、新規ワクチンの研究開発とワクチンデリバリーシステムの進歩は、市場でかなりの需要につながるでしょう。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • ヒト用ワクチンの市場規模
  • ヒト用ワクチンの市場予測
  • ヒト用ワクチン市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要なヒト用ワクチン市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ Astellas Pharma Inc.
    ➣ AstraZeneca Plc
    ➣ Bavarian Nordic AS
    ➣ Bharat Biotech Ltd.
    ➣ BioNTech SE
    ➣ CanSino Biologics Inc.
    ➣ CSL Ltd.
    ➣ 第一三共(Daiichi Sankyo Co. Ltd.)
    ➣ Emergent BioSolutions Inc.
    ➣ GlaxoSmithKline Plc
    ➣ Gradalis Inc.
    ➣ Inovio Pharmaceuticals Inc.
    ➣ Johnson and Johnson
    ➣ Merck and Co. Inc.
    ➣ 三菱ケミカルホールディングス(Mitsubishi Chemical Holdings Corp.)
    ➣ Moderna Inc., Novavax Inc.
    ➣ Pfizer Inc.
    ➣ Sanofi
    ➣ Serum Institute of India Pvt. Ltd.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Route of Administration
5.1 Market segments
Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)
5.2 Comparison by Route of Administration
Exhibit 26: Chart on Comparison by Route of Administration
Exhibit 27: Data Table on Comparison by Route of Administration
5.3 Intramuscular - Market size and forecast 2021-2026
Exhibit 28: Chart on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Intramuscular - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Intramuscular - Year-over-year growth 2021-2026 (%)
5.4 Subcutaneous - Market size and forecast 2021-2026
Exhibit 32: Chart on Subcutaneous - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Subcutaneous - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Subcutaneous - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Subcutaneous - Year-over-year growth 2021-2026 (%)
5.5 Oral - Market size and forecast 2021-2026
Exhibit 36: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Oral - Year-over-year growth 2021-2026 (%)
5.6 Others - Market size and forecast 2021-2026
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Route of Administration
Exhibit 44: Market opportunity by Route of Administration ($ million)

6 Customer Landscape
6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business

10 Vendor Analysis
10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 Bavarian Nordic AS
Exhibit 93: Bavarian Nordic AS - Overview
Exhibit 94: Bavarian Nordic AS - Product / Service
Exhibit 95: Bavarian Nordic AS - Key news
Exhibit 96: Bavarian Nordic AS - Key offerings
10.4 CSL Ltd.
Exhibit 97: CSL Ltd. - Overview
Exhibit 98: CSL Ltd. - Business segments
Exhibit 99: CSL Ltd. - Key news
Exhibit 100: CSL Ltd. - Key offerings
Exhibit 101: CSL Ltd. - Segment focus
10.5 Daiichi Sankyo Co. Ltd.
Exhibit 102: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 103: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 104: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 105: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 106: Daiichi Sankyo Co. Ltd. - Segment focus
10.6 GlaxoSmithKline Plc
Exhibit 107: GlaxoSmithKline Plc - Overview
Exhibit 108: GlaxoSmithKline Plc - Business segments
Exhibit 109: GlaxoSmithKline Plc - Key news
Exhibit 110: GlaxoSmithKline Plc - Key offerings
Exhibit 111: GlaxoSmithKline Plc - Segment focus
10.7 Inovio Pharmaceuticals Inc.
Exhibit 112: Inovio Pharmaceuticals Inc. - Overview
Exhibit 113: Inovio Pharmaceuticals Inc. - Product / Service
Exhibit 114: Inovio Pharmaceuticals Inc. - Key offerings
10.8 Merck and Co. Inc.
Exhibit 115: Merck and Co. Inc. - Overview
Exhibit 116: Merck and Co. Inc. - Business segments
Exhibit 117: Merck and Co. Inc. - Key news
Exhibit 118: Merck and Co. Inc. - Key offerings
Exhibit 119: Merck and Co. Inc. - Segment focus
10.9 Mitsubishi Chemical Holdings Corp.
Exhibit 120: Mitsubishi Chemical Holdings Corp. - Overview
Exhibit 121: Mitsubishi Chemical Holdings Corp. - Business segments
Exhibit 122: Mitsubishi Chemical Holdings Corp. - Key offerings
Exhibit 123: Mitsubishi Chemical Holdings Corp. - Segment focus
10.10 Pfizer Inc.
Exhibit 124: Pfizer Inc. - Overview
Exhibit 125: Pfizer Inc. - Product / Service
Exhibit 126: Pfizer Inc. - Key news
Exhibit 127: Pfizer Inc. - Key offerings
10.11 Sanofi
Exhibit 128: Sanofi - Overview
Exhibit 129: Sanofi - Business segments
Exhibit 130: Sanofi - Key news
Exhibit 131: Sanofi - Key offerings
Exhibit 132: Sanofi - Segment focus
10.12 Serum Institute of India Pvt. Ltd.
Exhibit 133: Serum Institute of India Pvt. Ltd. - Overview
Exhibit 134: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibit 135: Serum Institute of India Pvt. Ltd. - Key offerings

11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 136: Inclusions checklist
Exhibit 137: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 138: Currency conversion rates for US$
11.4 Research methodology
Exhibit 139: Research methodology
Exhibit 140: Validation techniques employed for market sizing
Exhibit 141: Information sources
11.5 List of abbreviations
Exhibit 142: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibits25: Data Table on Route of Administration - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Route of Administration
Exhibits27: Data Table on Comparison by Route of Administration
Exhibits28: Chart on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Intramuscular - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Intramuscular - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Subcutaneous - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Subcutaneous - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Subcutaneous - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Subcutaneous - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Oral - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Route of Administration ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: Bavarian Nordic AS - Overview
Exhibits94: Bavarian Nordic AS - Product / Service
Exhibits95: Bavarian Nordic AS - Key news
Exhibits96: Bavarian Nordic AS - Key offerings
Exhibits97: CSL Ltd. - Overview
Exhibits98: CSL Ltd. - Business segments
Exhibits99: CSL Ltd. - Key news
Exhibits100: CSL Ltd. - Key offerings
Exhibits101: CSL Ltd. - Segment focus
Exhibits102: Daiichi Sankyo Co. Ltd. - Overview
Exhibits103: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits104: Daiichi Sankyo Co. Ltd. - Key news
Exhibits105: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits106: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits107: GlaxoSmithKline Plc - Overview
Exhibits108: GlaxoSmithKline Plc - Business segments
Exhibits109: GlaxoSmithKline Plc - Key news
Exhibits110: GlaxoSmithKline Plc - Key offerings
Exhibits111: GlaxoSmithKline Plc - Segment focus
Exhibits112: Inovio Pharmaceuticals Inc. - Overview
Exhibits113: Inovio Pharmaceuticals Inc. - Product / Service
Exhibits114: Inovio Pharmaceuticals Inc. - Key offerings
Exhibits115: Merck and Co. Inc. - Overview
Exhibits116: Merck and Co. Inc. - Business segments
Exhibits117: Merck and Co. Inc. - Key news
Exhibits118: Merck and Co. Inc. - Key offerings
Exhibits119: Merck and Co. Inc. - Segment focus
Exhibits120: Mitsubishi Chemical Holdings Corp. - Overview
Exhibits121: Mitsubishi Chemical Holdings Corp. - Business segments
Exhibits122: Mitsubishi Chemical Holdings Corp. - Key offerings
Exhibits123: Mitsubishi Chemical Holdings Corp. - Segment focus
Exhibits124: Pfizer Inc. - Overview
Exhibits125: Pfizer Inc. - Product / Service
Exhibits126: Pfizer Inc. - Key news
Exhibits127: Pfizer Inc. - Key offerings
Exhibits128: Sanofi - Overview
Exhibits129: Sanofi - Business segments
Exhibits130: Sanofi - Key news
Exhibits131: Sanofi - Key offerings
Exhibits132: Sanofi - Segment focus
Exhibits133: Serum Institute of India Pvt. Ltd. - Overview
Exhibits134: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits135: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits136: Inclusions checklist
Exhibits137: Exclusions checklist
Exhibits138: Currency conversion rates for US$
Exhibits139: Research methodology
Exhibits140: Validation techniques employed for market sizing
Exhibits141: Information sources
Exhibits142: List of abbreviations

この商品のレポートナンバー

0000032033

TOP